Clinical Trial Update: The Use of Propranolol in the Perioperative Period of Resectable Gastrointestinal Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating propranolol in the perioperative period for patients with resectable gastrointestinal tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Neoplasms

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Huashan Hospital | Conditions: Gastrointestinal Tumors | Phase 2 | Status: RECRUITING